ArticleDiscover oncology2025

Comprehensive multi-omics analysis of histone acetylation modulators identifies ASH1L as a novel aggressive marker for osteosarcoma.

Chenlie Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.